Your browser doesn't support javascript.
loading
Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer.
Luo, Zhangyi; Xu, Jieni; Sun, Jingjing; Huang, Haozhe; Zhang, Ziqian; Ma, Weina; Wan, Zhuoya; Liu, Yangwuyue; Pardeshi, Apurva; Li, Song.
Affiliation
  • Luo Z; Center for pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, United States; University of Pittsburgh Cancer Institute, University of Pittsburgh, PA 15261, United States.
  • Xu J; Center for pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, United States; University of Pittsburgh Cancer Institute, University of Pittsburgh, PA 15261, United States.
  • Sun J; Center for pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, United States; University of Pittsburgh Cancer Institute, University of Pittsburgh, PA 15261, United States.
  • Huang H; Center for pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, United States; University of Pittsburgh Cancer Institute, University of Pittsburgh, PA 15261, United States.
  • Zhang Z; Center for pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, United States; University of Pittsburgh Cancer Institute, University of Pittsburgh, PA 15261, United States.
  • Ma W; Center for pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, United States; University of Pittsburgh Cancer Institute, University of Pittsburgh, PA 15261, United States.
  • Wan Z; Center for pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, United States; University of Pittsburgh Cancer Institute, University of Pittsburgh, PA 15261, United States.
  • Liu Y; Center for pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, United States; University of Pittsburgh Cancer Institute, University of Pittsburgh, PA 15261, United States.
  • Pardeshi A; Center for pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, United States; University of Pittsburgh Cancer Institute, University of Pittsburgh, PA 15261, United States.
  • Li S; Center for pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, United States; University of Pittsburgh Cancer Institute, University of Pittsburgh, PA 15261, United States. Electronic address: Sol4@pitt.edu.
Acta Biomater ; 105: 239-252, 2020 03 15.
Article in En | MEDLINE | ID: mdl-31958597
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prodrugs / Deoxyglucose / Glutamine / Micelles / Neoplasms Limits: Animals / Female / Humans Language: En Journal: Acta Biomater Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prodrugs / Deoxyglucose / Glutamine / Micelles / Neoplasms Limits: Animals / Female / Humans Language: En Journal: Acta Biomater Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom